Latest Galapagos News & Updates
See the latest news and media coverage for Galapagos. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing therapeutics for serious diseases
glpg.com- Headquarters
- Mechelen, Belgium
- Founded year
- 1999
- Company type
- Public company
- Number of employees
- 200–800
Latest news about Galapagos
Company announcements
-
Galapagos shareholders adopt all board-proposed resolutions
The AGM approved reports, director remuneration, appointments including Henry Gosebruch as Executive Director, and auditor re-appointment. The EGM approved name change to Lakefront Biotherapeutics and share authorizations.
-
Galapagos enters binding agreement with Gilead
The collaboration advances gamgertamig, a T cell engager for autoimmune diseases, via Gilead's Ouro acquisition. Galapagos gains licenses, assets, and improved financial terms.
-
Galapagos nominates Gino Santini to its Board of Directors
Subject to shareholder approval, he will succeed Jérôme Contamine as Chair. Santini brings extensive governance and business development experience.
-
Galapagos publishes 2025 annual report
It announces Annual and Extraordinary Shareholders’ Meetings on April 28, 2026, with agendas including director appointments and name change to Lakefront Biotherapeutics.
Media coverage
-
Little remains of the Dutch-Belgian biopharma promise Galapagos
NRC Insider Knowledge: Galapagos is no more. The once so promising Dutch-Belgian biopharmaceutical is now going by the name Lakefront Biotherapeutics. Of what was once Galapagos...
-
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the Company’s Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) held on...
-
Galapagos becomes Lakefront Biotechnologies
Galapagos will change its name to Lakefront Biotechnologies as of May 8, after the shareholders approved this proposal on Tuesday. The biotech company announced this on Tuesday.
-
Rebranded Belgian biotech lands $125M for rescued Galapagos drug candidates
After launching in 2025 as a refuge for shipwrecked assets from Galapagos, Onco3R Therapeutics is rebranding as Coultreon ...
Track Galapagos and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO